These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case. Milano M, Wright T, Loechner KJ. Pediatr Dent; 2011; 33(4):349-52. PubMed ID: 21903004 [Abstract] [Full Text] [Related]
3. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. Malmgren B, Aström E, Söderhäll S. J Oral Pathol Med; 2008 Apr; 37(4):196-200. PubMed ID: 18321345 [Abstract] [Full Text] [Related]
8. [Bisphosphonate-associated osteonecrosis of the jaws. 2. Six case reports]. Kicken M, Van Cann EM, Koole R. Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):428-31. PubMed ID: 17972611 [Abstract] [Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Brown JJ, Ramalingam L, Zacharin MR. Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397 [Abstract] [Full Text] [Related]
16. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. King AE, Umland EM. Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663 [Abstract] [Full Text] [Related]
17. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Malden N, Beltes C, Lopes V. Br Dent J; 2009 Jan 24; 206(2):93-8. PubMed ID: 19165270 [Abstract] [Full Text] [Related]
19. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases]. Gering A, Grange L, Villier C, Woeller A, Mallaret M. Therapie; 2007 Jan 24; 62(1):49-54. PubMed ID: 17374348 [Abstract] [Full Text] [Related]
20. [Osteonecrosis of the jaw and bisphophonates in oncology]. Facon T, Bensadoun RJ, Blanc JL, Confavreux C, Gourmet R, Maes JM, Penel G, Vieillard MH, Woeller A. Bull Cancer; 2008 Apr 24; 95(4):413-8. PubMed ID: 18495570 [Abstract] [Full Text] [Related] Page: [Next] [New Search]